CURRENT STATUS
AI detecting cancers years early from blood tests (Grail Galleri). CRISPR-edited CAR-T cells achieving complete remissions. AlphaFold accelerating neoantigen vaccine design. Personalized mRNA cancer vaccines in Phase III.
KEY BREAKTHROUGHS
Grail Galleri — multi-cancer early detection from a single blood draw, detecting 50+ cancer types
BioNTech/Moderna personalized mRNA cancer vaccines in Phase III for melanoma and pancreatic cancer
CRISPR-edited CAR-T cells (CTX110) achieving remissions without donor matching
AI-designed drug Recursion REC-4881 entering Phase II for familial adenomatous polyposis
AI-COMPRESSED PIPELINE
AI TOOLS ACCELERATING CURES
Multi-Cancer Early DetectionNeoantigen Prediction AICRISPR CAR-T EngineeringTumor Digital Twins
KEY ORGANIZATIONS
Grail (Illumina)BioNTechModernaCRISPR TherapeuticsRecursionFoundation Medicine
TIMELINE ESTIMATE
Early detection (all cancers): 2–3 years to routine screening. Personalized vaccines: 3–5 years. Pan-cancer cure: 10–15 years.